All In Biotech

Drug Trial Radar · NCT00893841

Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride

A Randomized, Double-Blind, Placebo Controlled Exploratory Study of Augmentation of Seroquel XR With Pramipexole Dihydrochloride for Bipolar Depression

Last checked: Nov 19, 2026Latest source record: Feb 4, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

96

Actual

Start

Feb 2009

Primary completion

Jan 2013

Study completion Jan 2013

Sponsor

Lead sponsor
Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
AstraZeneca
First posted
May 6, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to assess the use of pramipexole dihydrochloride and quetiapine (Seroquel) XR as combination therapy for bipolar depression. The proposed benefit of the combination therapy investigated in this study is improved treatment of bipolar depression.

Conditions

  • Bipolar Depression

Interventions

  • quetiapine (Seroquel) XRDrug

    tablets and caplets, take with liquid before bedtime

  • quetiapine (Seroquel) XRDrug

    tablets, take with liquid before bedtime

  • placeboDrug

    placebo

  • pramipexole dihydrochlorideDrug

    tablets and caplets, take with liquid before bedtime

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Montgomery-Asberg Depression Rating Scale (MADRS) total scoreTime frame: Week 0 to Week 16

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • Affiliated Research Institute

    San Diego, California

  • Eastside Therapeutic Resource

    Kirkland, Washington

  • Dr. P. Chokka

    Edmonton, Alberta, Canada

  • Penticton Regional

    Penticton, British Columbia, Canada

  • Copeman Neuroscience Centre

    Vancouver, British Columbia, Canada

  • AK Munshi Medical Inc.

    Sydney, Nova Scotia, Canada

  • Regional Mental Health Care - London

    London, Ontario, Canada

  • Hôpital Louis-H.Lafontaine

    Montreal, Quebec, Canada

  • Clinique Marie Fitzbach

    Québec, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.